Efficacy of Salmeterol Xinafoate in the Treatment of COPD

This publication has 21 references indexed in Scilit:

• Short-term Effects of Inhaled β-Adrenergic Agonist on Breathlessness and Central Inspiratory Drive in Patients With Nonreversible COPD
  Chest, 1996
• Timed Walking Tests of Exercise Capacity in Chronic Cardiopulmonary Illness
  Journal of Cardiopulmonary Rehabilitation, 1996
• Is an Anticholinergic Agent Superior to a β2-Agonist in Improving Dyspnea and Exercise Limitation in COPD?
  Chest, 1995
• Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
  Thorax, 1995
• Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study
  Respiratory Medicine, 1995
• Effect of Salmeterol and Formoterol in Patients with Chronic Obstructive Pulmonary Disease
  Pulmonary Pharmacology, 1994
• Management of Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 1993
• Bronchodilator Responses to Anticholinergic and Beta-Adrenergic Agents in Acute and Stable COPD
  Chest, 1991
• A measure of quality of life for clinical trials in chronic lung disease.
  Thorax, 1987
• Efficacy of Inhaled Metaproterenol and Orally-administered Theophylline in Patients with Chronic Airflow Obstruction
  Chest, 1986